PharmaXcelerate 2026 brings together senior leaders, innovators, and decision-makers from the pharmaceutical and biotech sectors to explore the next frontier of manufacturing excellence. Taking place on 8–9 June 2026 in London, this summit focuses on leveraging advanced technologies, digital transformation, and regulatory innovation to drive operational performance, resilience, and patient access.

Across two days, delegates will engage with thought leaders from global companies, including Roche, Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, Novo Nordisk, alongside European regulatory and engineering authorities. The agenda combines keynote presentations, case studies, and interactive sessions covering AI-enabled production, advanced automation, digital twins, serialization, and smart manufacturing strategies. Participants will gain actionable insights into optimizing capital projects, implementing risk- and science-based commissioning, enhancing quality systems, and deploying generative AI and machine learning solutions in clinical and manufacturing contexts.

This year’s summit emphasizes cross-industry collaboration, practical solutions, and the integration of technology and operations to de-risk projects, accelerate timelines, and reduce costs while maintaining compliance and product quality. Delegates will also benefit from exclusive networking opportunities, executive roundtables, and access to the latest tools and methodologies shaping the future of pharma and biotech production.

PharmaXcelerate 2026 is the premier platform for executives, engineers, and innovators seeking to transform manufacturing, drive operational excellence, and harness digital innovation across the global life sciences industry. Join us to connect with peers, learn from experts, and explore the technologies and strategies defining the future of pharma and biotech manufacturing.